Nalaganje...
An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
Immune checkpoint inhibitors (ICIs) are novel treatments that significantly improve the survival time of MIBC patients, but immunotherapeutic responses are different among MIBC patients. Therefore, it is urgent to find predictive biomarkers that can accurately identify MIBC patients who are sensitiv...
Shranjeno v:
| izdano v: | Cancer Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7163112/ https://ncbi.nlm.nih.gov/pubmed/32096345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2942 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|